Valuation: Quest Laboratories Limited

Market Cap 1.51B 15.66M 13.91M 12.98M 11.83M 22.32M 22.53M 157M 60.89M 769M 58.78M 57.51M 2.47B P/E 2025
12.4x
P/E 2026 11.5x
Enterprise Value 1.46B 15.2M 13.5M 12.6M 11.49M 21.67M 21.87M 153M 59.11M 747M 57.07M 55.83M 2.4B EV / Sales 2025
1.43x
EV / Sales 2026 1.49x
Free-Float
99%
Yield 2025 *
-
Yield 2026 -
1 day-8.33%
1 week+5.51%
Current month-8.33%
1 month+7.43%
3 months-3.26%
6 months-12.48%
Current year-16.58%
1 week 81
Extreme 81
102.4
1 month 68.6
Extreme 68.6
102.4
Current year 68.6
Extreme 68.6
152.6
1 year 68.6
Extreme 68.6
152.6
3 years 68.6
Extreme 68.6
196.8
5 years 68.6
Extreme 68.6
196.8
10 years 68.6
Extreme 68.6
196.8
Manager TitleAgeSince
Chief Executive Officer 59 31/12/2023
Director of Finance/CFO 38 31/12/2023
Compliance Officer - 02/09/2025
Director TitleAgeSince
Chairman 59 31/12/2023
Director/Board Member 31 04/03/2021
Director/Board Member 73 09/01/2024
Change 5-day change 1-year change 3-year change Capi.($)
-8.33%+5.51%-2.75% - 15.66M
-0.61%-3.43%+36.07%+115.04% 1,019B
-1.02%-5.60%+35.72%+64.63% 617B
+1.11%-0.58%+12.36%+77.95% 464B
+0.34%-3.01%+61.79%+41.24% 356B
-0.95%-4.05%+20.54%+41.71% 333B
-1.46%-2.89%+10.57%+32.81% 267B
-1.35%-5.43%-6.17%+8.98% 244B
-1.04%-2.79%+35.30%+51.84% 218B
-1.87%-4.10%+28.44%+93.66% 179B
Average -1.52%-2.99%+23.19%+58.65% 369.72B
Weighted average by Cap. -0.60%-3.54%+29.07%+70.57%

Financials

2025 2026
Net sales 1.04B 10.81M 9.61M 8.97M 8.17M 15.42M 15.56M 109M 42.06M 531M 40.6M 39.72M 1.71B 1.12B 11.63M 10.34M 9.65M 8.79M 16.58M 16.74M 117M 45.23M 572M 43.67M 42.72M 1.83B
Net income 136M 1.41M 1.25M 1.17M 1.07M 2.01M 2.03M 14.16M 5.49M 69.35M 5.3M 5.18M 223M 149M 1.55M 1.37M 1.28M 1.17M 2.21M 2.23M 15.52M 6.02M 76.02M 5.81M 5.68M 244M
Net Debt -191M -1.98M -1.76M -1.65M -1.5M -2.83M -2.86M -19.92M -7.72M -97.54M -7.45M -7.29M -313M -44M -458K -407K -380K -346K -653K -659K -4.59M -1.78M -22.5M -1.72M -1.68M -72.2M
Logo Quest Laboratories Limited
Quest Laboratories Limited is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC). These products are available in various forms, such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. The tablets include Cetirizine Hydrochloride Tablet IP 10 mg, Zinc Sulphate Dispersible Tablet IP, Diclofenac Sodium Tablet BP, and others. It offers dry syrup and suspension, such as Ferrous Sulphate & Folic Acid Syrup, Albendazole Suspension IP, Zinc Oral Solution USP, Alpha Amilase & Pepsine, Sucralfate Suspension, and others. Its ointments include Silver Sulphadiazine Cream IP, Diclofenac Diethylamino IP Gel, and Povidone Iodine Ointment USP.
Employees
99
Date Price Change Volume
01/10/26 ₹91.85 -8.33% 39,600
30/09/26 ₹100.20 +12.58% 220,800
29/09/26 ₹89.00 +3.79% 28,800
28/09/26 ₹85.75 -1.49% 7,200
  1. Stock Market
  2. Stocks
  3. QUESTLAB Stock